Grapevine, TX, July 21, 2025 (GLOBE NEWSWIRE) -- The Wholesome Company, a wellness brand focused on holistic and evidence-aligned support for mental well-being, is pleased to announce the launch of Rē•prev, a breakthrough nutritional supplement formulated to help individuals reduce anxiousness, manage stress, and improve sleep quality. Designed for rapid absorption and daily use, Rē•prev combines naturally calming ingredients with a flexible, easy-to-use format aimed at supporting emotional resilience in today’s high-stress landscape.
Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery
SEOUL, South Korea, July 20, 2025 /PRNewswire/ -- CorestemChemon, a leading GLP-certified preclinical...
BIRMINGHAM, Ala. and CLEVELAND, Tenn., July 18, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation...
NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global technetium-99m market is witnessing substantial...
NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global technetium-99m market is witnessing substantial...
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.
The Conference Forum announces the 15th annual PODD Drug Delivery Conference's 2025 agenda and featured sessions.
NEW YORK, July 16, 2025 /PRNewswire/ -- Today, PODD: Partnership...
EXOMIND launch event slated for July 25
SCOTTSDALE, Ariz., July 15, 2025 /PRNewswire/ -- For those seeking to lessen their anxiety, treat depression or enhance...
LOS ANGELES, July 15, 2025 /PRNewswire/ -- For Jim Kirtley, the executive director of the Palisades-Malibu YMCA, the most painful part of having the...
Joint effort to explore innovative cancer treatment solutions and broaden options for customers
HONG KONG, July 15, 2025 /PRNewswire/ -- AXA China Region Insurance Company...
SYDNEY, July 15, 2025 /PRNewswire/ -- Miroma Project Factory (MPF), a leader in digital innovation for health and wellbeing, is proud to announce the...
While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....